[S(R)]-N-[(S)-[2-(二苯基膦基)苯基]-(1,1'-联苯)甲基] -2-甲基-2-丙烷亚磺酰胺,95% [S(R)]-N-[(S)-[2-(Diphenylphosphino)phenyl]-(1,1'-biphenyl)methyl]-2-methyl-2-propanesulfinamide, 95%
-
[S(R)]-N-[(S)-1- [2-(二环己基膦基)苯基]-(1,1'-联苯)甲基] -2-甲基-2-丙烷亚磺酰胺,95% [S(R)]-N-[(S)-1-[2-(Dicyclohexylphosphino)phenyl]-(1,1'-biphenyl)methyl]-2-methyl-2-propanesulfinamide, 95%
ZMR-15-8432 | 50mg
-
[S(R)]-N-[(S)-1-[2-(二苯基膦)苯基]-(1,1'-联苯)甲基]-2-叔丁基亚磺酰胺 [S(R)]-N-[(S)-[2-(Diphenylphosphino)phenyl]-(1,1'-biphenyl)methyl]-2-methyl-2-propanesulfinamide
S56949-500mg | 500mg
-
[S(R)]-N-[(S)-[2-(二苯基膦基)苯基]苯基甲基] -N,2-二甲基-2-丙烷亚磺酰胺,95% [S(R)]-N-[(S)-[2-(Diphenylphosphino)phenyl]phenylmethyl]-N,2-dimethyl-2-propanesulfinamide, 95%
ZMR-15-8332 | 50mg
-
[S(R)]-N-[(S)-[(3-(苄氧基)-2-(二环己基膦基)苯基]-(1,1'-联苯)甲基] -N,2-二甲基-2-丙烷亚磺酰胺 ,95% [S(R)]-N-[(S)-[(3-(Benzyloxy)-2-(dicyclohexylphosphino)phenyl]-(1,1'-biphenyl)methyl]-N,2-dimethyl-2-propanesulfinamide, 95%
ZMR-15-8478 | 25mg
-
[S(R)]-N-[(S)-[2-(二金刚膦膦基)苯基]苯基甲基] -2-甲基-2-丙烷亚磺酰胺,95% [S(R)]-N-[(S)-[2-(Diadamantanphosphino)phenyl]phenylmethyl]-2-methyl-2-propanesulfinamide, 95%
ZMR-15-8490 | 50mg
-
[S(R)]-N-[(S)-[2-(二苯基膦基)苯基] -1-萘甲基] -2-甲基-2-丙烷亚磺酰胺,95% [S(R)]-N-[(S)-[2-(Diphenylphosphino)phenyl]-1-naphthalenylmethyl]-2-methyl-2-propanesulfinamide, 95%
ZMR-15-8322 | 100mg
-
[S(R)]-N-[(S)-[2-(二苯基膦基)苯基](4-甲氧基苯基)甲基] -N,2-二甲基-2-丙烷亚磺酰胺,95% [S(R)]-N-[(S)-[2-(Diphenylphosphino)phenyl](4-methoxyphenyl)methyl]-N,2-dimethyl-2-propanesulfinamide, 95%
ZMR-15-8336 | 50mg
中文名称:[S(R)]-N-[(S)-[2-(二苯基膦基)苯基]-(1,1'-联苯)甲基] -2-甲基-2-丙烷亚磺酰胺,95%
英文名称:[S(R)]-N-[(S)-[2-(Diphenylphosphino)phenyl]-(1,1'-biphenyl)methyl]-2-methyl-2-propanesulfinamide, 95%
分子式:C35H34NOPS;分子量:547.7。
您正在浏览的产品:[S(R)]-N-[(S)-[2-(二苯基膦基)苯基]-(1,1'-联苯)甲基] -2-甲基-2-丙烷亚磺酰胺,95%
手机版:[S(R)]-N-[(S)-[2-(二苯基膦基)苯基]-(1,1'-联苯)甲基] -2-甲基-2-丙烷亚磺酰胺,95%
本公司销售的所有产品仅供实验科研使用,不用于人体及临床诊断。
2. 色谱条件:流动相为乙腈-水(含0.1%三氟乙酸),流速1.0 mL/min,柱温30℃;
3. 质控点:每10个样品插入平行样和空白样。
2. 亚磺酰胺类化合物在酸性条件下可能消旋,流动相pH应控制在6.5-7.5;
3. 标准物质储存条件:-20℃避光密封,开封后需氮气保护。
以上信息仅供参考,请以相应标准的原文为准!